Amgen Inc AMGN:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD

Last | 3:27 PM EDT

305.78

-0.72 (-0.23%)

Volume

817,748

52 week range

211.71 - 329.72

Open306.42
Day High307.50
Day Low303.90
Prev Close306.50
52 Week High329.72
52 Week High Date02/05/24
52 Week Low211.71
52 Week Low Date06/01/23

Key Stats

Market Cap164.031B
Shares Out536.43M
10 Day Average Volume2.17M
Dividend9.00
Dividend Yield2.94%
Beta0.61
YTD % Change6.23

KEY STATS

Open306.42
Day High307.50
Day Low303.90
Prev Close306.50
52 Week High329.72
52 Week High Date02/05/24
52 Week Low211.71
52 Week Low Date06/01/23
Market Cap164.031B
Shares Out536.43M
10 Day Average Volume2.17M
Dividend9.00
Dividend Yield2.94%
Beta0.61
YTD % Change6.23

RATIOS/PROFITABILITY

EPS (TTM)7.00
P/E (TTM)43.69
Fwd P/E (NTM)15.77
EBITDA (TTM)11.625B
ROE (TTM)72.57%
Revenue (TTM)29.532B
Gross Margin (TTM)66.38%
Net Margin (TTM)12.74%
Debt To Equity (MRQ)1,274.79%

EVENTS

Earnings Date08/01/2024(est)
Ex Div Date05/16/2024
Div Amount2.25
Split Date-
Split Factor-

Latest On Amgen Inc

AstraZeneca to boost revenue as it plans to release 20 new medicines by 2030May 21, 2024CNBC.com
Trade Tracker: The Investment Committee details their latest portfolio movesMay 17, 2024CNBC.com
FDA approves Amgen's treatment for most deadly form of lung cancer May 16, 2024CNBC.com
Lilly falls on a rival's study — plus, we're removing 3 stocks from our watchlist May 16, 2024CNBC.com
Trade Tracker: Joe Terranova buys Amgen and MerckMay 15, 2024CNBC.com

Content From Our Affiliates

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Omnicell (OMCL), Tandem Diabetes Care (TNDM) and Amgen (AMGN)May 22, 2024TipRanks
Maintaining Hold on Amgen: Mixed Clinical Results and Cautious Adoption of New TherapyMay 22, 2024TipRanks
Tezspire’s Potential in COPD Treatment: Navigating Efficacy and Market DynamicsMay 22, 2024TipRanks
Analysts’ Top Healthcare Picks: GE Healthcare Technologies Inc (GEHC), Compugen (CGEN)May 21, 2024TipRanks
Amgen (AMGN) Gets a Buy from Truist FinancialMay 21, 2024TipRanks

Profile

Amgen Inc. is a biotechnology company. The Company discovers, develops, manufactures and delivers various human therapeutics. It focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and improve people's lives. It operates in human therapeutics segment. The Company’s marketed products portfolio includes Aranesp, ENBREL, Prolia (denosumab), Neulasta (pegfilgrastim), Otezla, XGEVA, Aranesp (darbepoetin...

Robert Bradway

Chairman of the Board, President, Chief Executive Officer

Peter Griffith

Chief Financial Officer, Executive Vice President

David Reese

Executive Vice President, Chief Technology Officer

Murdo Gordon

Executive Vice President - Global Commercial Operations

Esteban Santos

Executive Vice President - Operations

Address

One Amgen Center Drive

Thousand Oaks, CA

91320

United States

https://www.amgen.com/

Top Peers

SYMBOL	LAST	CHG	%CHG
PFE Pfizer Inc	28.75	+0.06	+0.21%
NVS Novartis AG	100.52	-0.59	-0.58%
SNY Sanofi SA	48.63	-0.37	-0.76%
GILD Gilead Sciences Inc	65.37	-0.80	-1.21%
GSK GSK plc	45.09	-0.05	-0.12%